99 filings
Page 2 of 5
424B5
ooreyp
2 Jan 24
Prospectus supplement for primary offering
4:54pm
8-K
lmivfk5v41itgiw7
2 Jan 24
Results of Operations and Financial Condition
4:02pm
8-K
ir36pnvg7pcaqd
2 Jan 24
Regulation FD Disclosure
9:44am
8-K
1m7ad
29 Nov 23
Regulation FD Disclosure
8:35am
8-K
8tqfo38s ichp0f4vh
2 Nov 23
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:05pm
8-K
8bnceb6o
11 Oct 23
Regulation FD Disclosure
9:26am
8-K
6suk38d 3yhuo1
22 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:21pm
8-K
3r3apfa
23 Aug 23
Enrolled 52 participants with Developmental and Epileptic Encephalopathies (DEEs) into the PACIFIC Study
8:46am
EFFECT
ua7p2 repjg4yrbcgpy
14 Aug 23
Notice of effectiveness
12:15am
CORRESP
7jod8f3p p3wb
9 Aug 23
Correspondence with SEC
12:00am
UPLOAD
r3y ewbhi
8 Aug 23
Letter from SEC
12:00am
8-K
r9fh8
4 Aug 23
Other Events
5:00pm
424B5
5v3ul
4 Aug 23
Prospectus supplement for primary offering
4:20pm
8-K
gdgecoan
3 Aug 23
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:12pm
8-K
ant2p2k
26 May 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
djkoke t9
9 May 23
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm